Overview

Exenatide Once Weekly for Smoking Cessation

Status:
Completed
Trial end date:
2020-01-03
Target enrollment:
Participant gender:
Summary
The purpose of this study is to identify a potential new treatment for smoking cessation.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston
Collaborators:
Baylor College of Medicine
Michael Debakey Veterans Affairs Medical Center
Treatments:
Exenatide
Nicotine